Thanks for that asf - in some respects you're right. According...

Thanks for that asf - in some respects you're right. According to the ASX announcement of 1/11/12 it was returned to the vendor AML.

However, many previous ASX announcements made it clear that we had settled on acquiring 100% of AML. The most recent example of this is the 2012 Annual Report and specifically Note 21 (starting on page 101) outlines many aspects of the 'purchase'.

Note 24 of the same report also makes it clear we had a 100% equity stake in AML.

I think initially it cost us $1.4m in shares and then the rest was subject to milestones. Who knows what was spent on DD over the last 12 months.

P31 of the Annual Report says ... "Consegna has worked tirelessly throughout the year to look after and develop this valuable intellectual property portfolio".

So I'm not sure about it being a nil-sum event. Anyway, my focus is not so much on cost, its more about ownership of the asset & the IP associated with it.

Maybe FP could explain it more clearly at the AGM, as there appears to have been a number of conflicting statements made in the last year on this technology.